Tetanus toxoid-loaded layer-by-layer nanoassemblies for efficient systemic, mucosal, and cellular immunostimulatory response following oral administration

被引:12
作者
Harde, Harshad [1 ]
Agrawal, Ashish Kumar [1 ]
Jain, Sanyog [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Ctr Pharmaceut Nanotechnol, Sas Nagar 160062, Punjab, India
关键词
Tetanus toxoid; Layersomes; Vaccine; Oral delivery; Immune response; FORMULATION DEVELOPMENT; IMPROVED STABILITY; IMMUNE-RESPONSES; VACCINE ADJUVANT; NANOPARTICLES; DELIVERY; CHITOSAN; MICROSPHERE; PROTECTION; LIPOSOMES;
D O I
10.1007/s13346-015-0247-x
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
The present study reports the tetanus toxoid (TT)loaded layer-by-layer nanoassemblies (layersomes) with enhanced protection, permeation, and presentation for comprehensive oral immunization. The stable and lyophilized TT-loaded layersomes were prepared by a thin-film hydration method followed by alternate layer-by-layer coating of an electrolyte. The developed system was assessed for in vitro stability of antigen and formulation, cellular uptake, ex vivo intestinal uptake, and immunostimulatory response using a suitable experimental protocol. Layersomes improved the stability in simulated biological media as well as protected the integrity/conformation and native 3D structure of TT as confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), circular dichroism (CD), and fluorescence spectroscopy, respectively. The cell culture studies demonstrated a 3.8-fold higher permeation of layersomes in Caco-2 cells and an 8.5-fold higher uptake by antigen-presenting cells (RAW 264.7). The TT-loaded layersomes elicited a complete immunostimulatory profile consisting of higher systemic (serum IgG titer), mucosal (sIgA titer), and cellular (interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) levels) immune response after peroral administration in mice. The modified TT inhibition assay further confirmed the elicitation of complete protective levels of anti-TT antibody (>0.1 IU/mL) by layersomes. In conclusion, the proposed strategy is expected to contribute significantly in the field of stable liposome technology for mass immunization through the oral route.
引用
收藏
页码:498 / 510
页数:13
相关论文
共 36 条
[1]   Freeze-drying of nanoparticles: Formulation, process and storage considerations [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Stainmesse, Serge ;
Fessi, Hatem .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1688-1713
[2]   Advances in immunology - Vaccines and vaccination [J].
Ada, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1042-1053
[3]   Improved Stability and Antidiabetic Potential of Insulin Containing Folic Acid Functionalized Polymer Stabilized Multi layered Liposomes Following Oral Administration [J].
Agrawal, Ashish Kumar ;
Harde, Harshad ;
Thanki, Kaushik ;
Jain, Sanyog .
BIOMACROMOLECULES, 2014, 15 (01) :350-360
[4]   Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application [J].
Benediktsdottir, Berglind Eva ;
Baldursson, Olafur ;
Masson, Mar .
JOURNAL OF CONTROLLED RELEASE, 2014, 173 :18-31
[5]  
Borrow R, 2006, IMMUNOLOGICAL BASIS, P8
[6]   Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach [J].
des Rieux, Anne ;
Fievez, Virginie ;
Garinot, Marie ;
Schneider, Yves-Jacques ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (01) :1-27
[7]  
Harde H., 2013, J NANOGENOM NANOMED, V1, P1
[8]   Divalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration [J].
Harde, Harshad ;
Siddhapura, Krupa ;
Agrawal, Ashish Kumar ;
Jain, Sanyog .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 487 (1-2) :292-304
[9]   Tetanus Toxoids Loaded Glucomannosylated Chitosan Based Nanohoming Vaccine Adjuvant with Improved Oral Stability and Immunostimulatory Response [J].
Harde, Harshad ;
Agrawal, Ashish Kumar ;
Jain, Sanyog .
PHARMACEUTICAL RESEARCH, 2015, 32 (01) :122-143
[10]  
Harde H, 2014, NANOMEDICINE-UK, V9, P2511, DOI [10.2217/NNM.13.225, 10.2217/nnm.13.225]